J3470 HCPCS code: Injection, hyaluronidase, up to 150 units
J3470 is the HCPCS Level II code for injection, hyaluronidase, up to 150 units. In 2024 Medicare paid an average of $42.83 per service for J3470 across 134 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 3 per day on outpatient hospital claims. Medicare volume fell 8% from 2022 to 2024 (146 to 134 services). In 2024, about 29 clinicians billed Medicare for J3470 for 94 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 1982-01-01 |
| Last action effective | 1997-01-01 |
Who bills J3470 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 29 |
| Medicare beneficiaries | 94 |
| States with claims | 2 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J3470, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 146 | 111 | $54.05 | $43.07 |
| 2023 | 136 | 98 | $55.73 | $43.94 |
| 2024 | 134 | 94 | $54.46 | $42.83 |
States with the most J3470 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| California | 77 | $45.37 |
| Florida | 28 | $41.53 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 3 | Clinical: Data |
| practitioner claims | 3 | Clinical: Data |
What changed for J3470
- 1982-01-01: J3470 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J3470?
J3470 is the HCPCS Level II code for injection, hyaluronidase, up to 150 units. Short descriptor: "Hyaluronidase injection".
How much does Medicare pay for J3470?
In 2024, the average Medicare payment was $42.83 per service (average allowed $54.46).
Does Medicare cover J3470?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
How many units of J3470 can be billed per day?
3 on outpatient hospital claims; 3 on practitioner claims (NCCI medically unlikely edits).
Related J34 codes
- J3400 — Injection, triflupromazine hcl, up to 20 mg
- J3401 — Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml
- J3402 — Injection, remestemcel-l-rknd, per therapeutic dose
- J3403 — Revakinagene taroretcel-lwey, per implant
- J3404 — Injection, zopapogene imadenovec-drba suspension, per therapeutic dose
- J3405 — Injection, onasemnogene abeparvovec-brve, per treatment
- J3406 — Injection, omidubicel-onlv, per therapeutic dose
- J3410 — Injection, hydroxyzine hcl, up to 25 mg
- J3411 — Injection, thiamine hcl, 100 mg
- J3415 — Injection, pyridoxine hcl, 100 mg
- J3420 — Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
- J3424 — Injection, hydroxocobalamin, intravenous, 25 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J3470
- Watch J3470 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J3470
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.